Epigallocatechin gallate supplementation alleviates diabetes in rodents - PubMed (original) (raw)

. 2006 Oct;136(10):2512-8.

doi: 10.1093/jn/136.10.2512.

Affiliations

• PMID: 16988119
• DOI: 10.1093/jn/136.10.2512

Free article

Epigallocatechin gallate supplementation alleviates diabetes in rodents

Swen Wolfram et al. J Nutr. 2006 Oct.

Free article

Abstract

As the prevalence of type 2 diabetes mellitus is increasing at an alarming rate, effective nutritional and exercise strategies for the prevention of this disease are required. Specific dietary components with antidiabetic efficacy could be one aspect of these strategies. This study investigated the antidiabetic effects of the most abundant green tea catechin, epigallocatechin gallate (EGCG, TEAVIGO), in rodent models of type 2 diabetes mellitus and H4IIE rat hepatoma cells. We assessed glucose and insulin tolerance in db/db mice and ZDF rats after they ingested EGCG. Using gene microarray and real-time quantitative RT-PCR we investigated the effect of EGCG on gene expression in H4IIE rat hepatoma cells as well as in liver and adipose tissue of db/db mice. EGCG improved oral glucose tolerance and blood glucose in food-deprived rats in a dose-dependent manner. Plasma concentrations of triacylglycerol were reduced and glucose-stimulated insulin secretion was enhanced. In H4IIE cells, EGCG downregulated genes involved in gluconeogenesis and the synthesis of fatty acids, triacylgycerol, and cholesterol. EGCG decreased the mRNA expression of phosphoenolpyruvate carboxykinase in H4IIE cells as well as in liver and adipose tissue of db/db mice. Glucokinase mRNA expression was upregulated in the liver of db/db mice in a dose-dependent manner. This study shows that EGCG beneficially modifies glucose and lipid metabolism in H4IIE cells and markedly enhances glucose tolerance in diabetic rodents. Dietary supplementation with EGCG could potentially contribute to nutritional strategies for the prevention and treatment of type 2 diabetes mellitus.

PubMed Disclaimer

Similar articles

• TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass.
  Wolfram S, Raederstorff D, Wang Y, Teixeira SR, Elste V, Weber P. Wolfram S, et al. Ann Nutr Metab. 2005 Jan-Feb;49(1):54-63. doi: 10.1159/000084178. Epub 2005 Feb 25. Ann Nutr Metab. 2005. PMID: 15735368
• Effects of a catechin-free fraction derived from green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells and in the mouse liver.
  Yasui K, Miyoshi N, Tanabe H, Ishigami Y, Fukutomi R, Imai S, Isemura M. Yasui K, et al. Biomed Res. 2011 Apr;32(2):119-25. doi: 10.2220/biomedres.32.119. Biomed Res. 2011. PMID: 21551947
• Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
  Lee MS, Kim CT, Kim Y. Lee MS, et al. Ann Nutr Metab. 2009;54(2):151-7. doi: 10.1159/000214834. Epub 2009 Apr 22. Ann Nutr Metab. 2009. PMID: 19390166
• Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
  Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML, Jois M, Sinclair AJ, Begg DP, Wark JD, Weisinger HS, Weisinger RS. Chen N, et al. Nutr Res. 2009 Nov;29(11):784-93. doi: 10.1016/j.nutres.2009.10.003. Nutr Res. 2009. PMID: 19932867
• Recent advances in understanding the anti-diabetic actions of dietary flavonoids.
  Babu PV, Liu D, Gilbert ER. Babu PV, et al. J Nutr Biochem. 2013 Nov;24(11):1777-89. doi: 10.1016/j.jnutbio.2013.06.003. Epub 2013 Sep 9. J Nutr Biochem. 2013. PMID: 24029069 Free PMC article. Review.

Cited by

• Role of microglia in diabetic neuropathic pain.
  Wang Q, Xie Y, Ma S, Luo H, Qiu Y. Wang Q, et al. Front Cell Dev Biol. 2024 Jul 29;12:1421191. doi: 10.3389/fcell.2024.1421191. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39135776 Free PMC article. Review.
• Complementary and alternative medicine for the treatment of type 2 diabetes.
  Nahas R, Moher M. Nahas R, et al. Can Fam Physician. 2009 Jun;55(6):591-6. Can Fam Physician. 2009. PMID: 19509199 Free PMC article. Review.
• Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice.
  Chen YK, Cheung C, Reuhl KR, Liu AB, Lee MJ, Lu YP, Yang CS. Chen YK, et al. J Agric Food Chem. 2011 Nov 9;59(21):11862-71. doi: 10.1021/jf2029016. Epub 2011 Oct 18. J Agric Food Chem. 2011. PMID: 21932846 Free PMC article.
• Metabolomics and molecular networking approach for exploring the anti-diabetic activity of medicinal plants.
  Timilsina AP, Raut BK, Huo C, Khadayat K, Budhathoki P, Ghimire M, Budhathoki R, Aryal N, Kim KH, Parajuli N. Timilsina AP, et al. RSC Adv. 2023 Oct 19;13(44):30665-30679. doi: 10.1039/d3ra04037b. eCollection 2023 Oct 18. RSC Adv. 2023. PMID: 37869390 Free PMC article.
• The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus.
  David JA, Rifkin WJ, Rabbani PS, Ceradini DJ. David JA, et al. J Diabetes Res. 2017;2017:4826724. doi: 10.1155/2017/4826724. Epub 2017 Aug 20. J Diabetes Res. 2017. PMID: 28913364 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal